|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 464 articles |
 Page 1 of 7 
|
Cinfa acquires 23.7% share of Spanish generics market.
April 28, 2008
Indian High Court restrains Cipla from exporting a generic of Roche's ...
April 28, 2008
Eisai names Robert Laverty VP, corporate communications at US unit.
April 28, 2008
NicOx signs deal with Archimica for production of naproxcinod.
April 28, 2008
Alizyme discontinues renzapride after poor Ph III data.
April 28, 2008
Pfizer to launch Champix in Japan.
April 28, 2008
Bayer files patent infringement lawsuit against Watson and Sandoz over...
April 28, 2008
Shire's Vyvanse cleared for ADHD in adults.
April 28, 2008
TopoTarget buys full control of belinostat from Curagen.
April 28, 2008
UCB's shares jump 23% as FDA approves Cimzia.
April 28, 2008
Express Scripts' US health cost initiative.
April 28, 2008
Co-pays for high price drugs soar in USA, says NYT.
April 28, 2008
FDA advisory c'tees "a high priority".
April 28, 2008
PharmaMar reports cancer drug results.(Financial report)
April 28, 2008
Almirall asthma drug's promising results.
April 28, 2008
UK's NHS Direct launches medicines health zone.
April 28, 2008
China denies heparin contamination.
April 28, 2008
Brazil to bypass patent for ARV drug Viread.
April 28, 2008
Japan stock market week to Aril 21, 2008.
April 28, 2008
Eurand's EUR-1008 eligible for EU centralized review.
April 28, 2008
Novartis cuts price of malaria drug Coartem 20%.
April 28, 2008
FDA delays release of ProStrakan's Sancuso.
April 28, 2008
Novartis markets vildagliptin in UK.
April 28, 2008
BioVex Phase III trials of Oncovex approved.
April 28, 2008
Correction: Peregrine's bavituximab.(Correction notice)
April 28, 2008
US Medicare Part D effects analysed.
April 28, 2008
GPhA: US e-pedigree rules must not hit access.
April 28, 2008
Stock Commentary - Europe - week to April 21, 2008.
April 28, 2008
Stock Commentary - New York week to April 21, 2008.
April 28, 2008
University IP activism impacts drug development.
April 28, 2008
Schering-Plough to sell animal health franchises to Pfizer.
April 28, 2008
Pfizer on track for greater shareholder value, says CEO.
April 28, 2008
Argos Thera secures $35.2M financing.
April 28, 2008
Resignations at AEterna Zentaris.
April 28, 2008
Acambis wins ten year $425.0 million US CDC contract.
April 28, 2008
US "shift" in dividing line between food and drugs.
April 28, 2008
Pramipexole reduces sleep disturbance in RLS.
April 28, 2008
Plasma exchange could address Tysabri PML profile.
April 28, 2008
GSK's RLS drug is well-tolerated.
April 28, 2008
Accentia Biopharm clarifies Nasdaq notice.
April 28, 2008
Investors buy share in Sangui BioTech GmbH.
April 28, 2008
Raptor starts Ph IIa Convivia trial.
April 28, 2008
Preclinical data confirms unique mechanism of bavituximab.
April 28, 2008
Pfizer 1st-qtr income slumps 18%, hit by generic competition and acqui...
April 28, 2008
GSK agrees to buy Sirtris for $720M to gain foothold in emerging field...
April 28, 2008
GSK's 1st-qtr 2008 EPS drops 5% on Avandia sales slump and generic com...
April 28, 2008
Mega drug licensing deal with GSK could bring Regulus Thereapeutics $6...
April 28, 2008
Pfizer in up to $390M deal for Avant drug.
April 28, 2008
Amer Oriental buys China Aoxing stake.
April 28, 2008
Abbott reports 35% rise in earnings.(Financial report)
April 28, 2008
Gilead record sales push revenue up 22%.
April 28, 2008
Baxter 2008 outlook up as 1Q results solid.
April 28, 2008
French drugmakers support EU patient rights day.
April 28, 2008
US govt criticizes Indonesia over H5N1 samples.
April 28, 2008
USTR calls for data exclusivity in India.
April 28, 2008
France's LEEM recruits associated industry members.
April 28, 2008
Strong Ph II data on Newron's ralfinamide.
April 28, 2008
Healthy worldwide uptake of Tysabri.
April 28, 2008
UCB's lacosamide cuts neuropathic pain.
April 28, 2008
Pfizer's Lyrica reduces fibromyalgia pain.
April 28, 2008
Takeda continues research accord with Chemizon.
April 28, 2008
Metabasis raises $10M to fund clinical programs.
April 28, 2008
Lilly streamlines Indianapolis operations with 500 staff cuts.
April 28, 2008
Positive results from Teva's PreCISe Copaxone study.
April 28, 2008
Vaccines and diagnostics help Swiss major Novartis beat expectations.(...
April 28, 2008
Nippon Boeh Ing again records fastest growth in Japan's ethical drug m...
April 28, 2008
GSK drops Japanese partner for Zantac.
April 28, 2008
India's Dabur goes to Fresenius for $220M.
April 28, 2008
Maryland OKs Medicaid reimbursement for ActiPatch.
April 28, 2008
Final FDA appro for Mylan's felodipine.
April 28, 2008
IFPMA report: policies to encourage drug R&D.
April 28, 2008
Pertussis vacc for all adults in France.
April 28, 2008
Demonstrations against French Rx tax.
April 28, 2008
AZ to work with Wash Uni on Alzheimer's.(Disease/Disorder overview)
April 28, 2008
Neovista's CABERNET trial to be expanded.
April 28, 2008
|
1